4 active warrant series; nearest expiry 2026-12-30.
Compare this book against every issuer →4 option grants covering 1,009,954 shares (~2.8% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.80 | Dec 30, 2026* 93d | 273K | ITM | 0.8% | C$219K | Auto |
| option | $5.48 | May 30, 2033 2436d | 242K | ITM | 0.7% | C$1.3M | Auto |
| option | $4.24 | Apr 30, 2034 2771d | 270K | ITM | 0.7% | C$1.1M | Auto |
| option | $8.76 | Jun 30, 2036 3563d | 225K | ITM | 0.6% | C$2.0M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
35,951,495 shares outstanding, plus 0 from warrants and 1,009,954 from options — a fully diluted 36,961,449 shares, or ~2.8% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
4 active warrant series; nearest expiry 2026-12-30.
Compare this book against every issuer →4 option grants covering 1,009,954 shares (~2.8% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.80 | Dec 30, 2026* 93d | 273K | ITM | 0.8% | C$219K | Auto |
| option | $5.48 | May 30, 2033 2436d | 242K | ITM | 0.7% | C$1.3M | Auto |
| option | $4.24 | Apr 30, 2034 2771d | 270K | ITM | 0.7% | C$1.1M | Auto |
| option | $8.76 | Jun 30, 2036 3563d | 225K | ITM | 0.6% | C$2.0M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
35,951,495 shares outstanding, plus 0 from warrants and 1,009,954 from options — a fully diluted 36,961,449 shares, or ~2.8% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
